Hian Leng Ngiam
Director/Board Member chez ESSEX BIO-TECHNOLOGY LIMITED
Fortune : 612 230 $ au 31/03/2024
Profil
Hian Leng Ngiam is currently the Executive Director at Essex Bio-Technology Ltd.
and the President & Director at Essex Bio-Investment Ltd.
He is also a Director at Antikor Biopharma Ltd., Essex Bio-Pharmacy Ltd., Essex Medipharma (Zhuhai) Co., Ltd., Zhuhai Essex Bio-Pharmaceutical Co., Ltd., Uno Medical Group Pvt Ltd., and Majeton Pte Ltd.
Mr. Ngiam completed his undergraduate degree at Imperial College London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 2 039 000 ( 0,36% ) | 612 230 $ | 31/03/2024 |
Postes actifs de Hian Leng Ngiam
| Sociétés | Poste | Début |
|---|---|---|
| ESSEX BIO-TECHNOLOGY LIMITED | Director/Board Member | 19/09/2020 |
Essex Bio-Investment Ltd.
 Essex Bio-Investment Ltd. Financial ConglomeratesFinance Part of Essex Bio-Technology Ltd., Essex Bio-Investment Ltd. is an investment holding There is no available country named vg company. The private company is based in Road Town, British Virgin Islands. | President | 01/01/2018 |
Zhuhai Essex Bio-Pharmaceutical Co., Ltd.
 Zhuhai Essex Bio-Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Essex Bio-Technology Ltd., Zhuhai Essex Bio-Pharmaceutical Co., Ltd. is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Zhuhai, China and was founded in 1999. | Director/Board Member | - |
| Essex Bio-Pharmacy Ltd. | Director/Board Member | - |
Antikor Biopharma Ltd.
 Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | Director/Board Member | 21/01/2019 |
| Majeton Pte Ltd. | Director/Board Member | - |
| Uno Medical Group Pvt Ltd. | Director/Board Member | - |
| Essex Medipharma (Zhuhai) Co., Ltd. | Director/Board Member | - |
Formation de Hian Leng Ngiam
| Imperial College London | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
| Essex Bio-Technology Ltd. | |
Essex Bio-Investment Ltd.
Essex Bio-Investment Ltd. Financial ConglomeratesFinance Part of Essex Bio-Technology Ltd., Essex Bio-Investment Ltd. is an investment holding There is no available country named vg company. The private company is based in Road Town, British Virgin Islands. | Finance |
Antikor Biopharma Ltd.
Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | Health Technology |
| Essex Bio-Pharmacy Ltd. | Finance |
| Essex Medipharma (Zhuhai) Co., Ltd. | |
| Uno Medical Group Pvt Ltd. | |
| Majeton Pte Ltd. | |
Zhuhai Essex Bio-Pharmaceutical Co., Ltd.
Zhuhai Essex Bio-Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Essex Bio-Technology Ltd., Zhuhai Essex Bio-Pharmaceutical Co., Ltd. is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Zhuhai, China and was founded in 1999. | Health Technology |
